JGCM
MRNA icon

Joseph Group Capital Management’s Moderna MRNA Stock Holding History

Joseph Group Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-60
Closed -$6.2K – 85
2023
Q3 		$6.2K Hold
60
– – ﹤0.01% 79
2023
Q2 		$7.29K Hold
60
– – 0.01% 74
2023
Q1 		$9.21K Hold
60
– – 0.01% 77
2022
Q4 		$11K Hold
60
– – 0.01% 84
2022
Q3 		$7K Hold
60
– – 0.01% 75
2022
Q2 		$9K Hold
60
– – 0.01% 66
2022
Q1 		$10K Buy
+60
New +$10.1K 0.01% 66

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Joseph Group Capital Management's MRNA Position: Q4 2023 in Review

Joseph Group Capital Management sold out of Moderna (MRNA) in Q4 2023, closing a stake of 60 shares — an estimated $6.2K sold.

Joseph Group Capital Management first reported a position in MRNA in Q1 2022 and held it in 7 quarters. The position peaked at $11K in Q4 2022. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Joseph Group Capital Management reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Joseph Group Capital Management sold 60 Moderna shares in Q4 2023, an estimated $6.2K.
  • Joseph Group Capital Management first reported a position in Moderna in Q1 2022 and held it in 7 quarters.
  • Joseph Group Capital Management's Moderna position peaked at $11K in Q4 2022.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Joseph Group Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.